Clinical-Based vs. Model-Based Adaptive Dosing Strategy: Retrospective Comparison in Real-World mRCC Patients Treated with Sunitinib

by Florent Ferrer, Jonathan Chauvin, Bénédicte DeVictor, Bruno Lacarelle, Jean-Laurent Deville, Joseph Ciccolini
Published 2021-05-01

265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort

by Luc Dirix, Frank Beier, Alain Ravaud, Theodore Gourdin, Jean-Laurent Deville, Marco Maruzzo, XiaoZhe Wang, Yulia Vugmeyster, Jeorg Seebeck, Sarah Chennoufi
Published 2020-11-01

Prognostic Value of the B12/CRP Index in Older Systemically Treatable Cancer Patients

by Coline Montegut, Florian Correard, Emilie Nouguerède, Dominique Rey, Thomas Chevalier, Marie Meurer, Jean-Laurent Deville, Marjorie Baciuchka, Vincent Pradel, Laurent Greillier, Patrick Villani, Anne-Laure Couderc
Published 2021-12-01

Stereotactic Body Radiotherapy for Frail Patients with Primary Renal Cell Carcinoma: Preliminary Results after 4 Years of Experience

by Laure Grelier, Michael Baboudjian, Bastien Gondran-Tellier, Anne-Laure Couderc, Robin McManus, Jean-Laurent Deville, Ana Carballeira, Raphaelle Delonca, Veronique Delaporte, Laetitia Padovani, Romain Boissier, Eric Lechevallier, Xavier Muracciole
Published 2021-06-01

First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma

by Renee N Donahue, Jeffrey Schlom, James L Gulley, Mario Sznol, Andreas Schroeder, Julius Strauss, Luc Dirix, Michele Maio, Frank Beier, Alain Ravaud, Jean-Laurent Deville, Marco Maruzzo, XiaoZhe Wang, Yulia Vugmeyster, Sarah Chennoufi, Yo-Ting Tsai, Russell K Pachynski, Theodore S Gourdin, Joerg Seebeck
Published 2023-05-01